Susan Hall - Net Worth and Insider Trading

Susan Hall Net Worth

The estimated net worth of Susan Hall is at least $5 dollars as of 2024-04-24. Susan Hall is the EVP, CSO, Global Head of R&D of Endo International PLC and owns about 7,515 shares of Endo International PLC (ENDPQ) stock worth over $5. Susan Hall is also the Global Head of R&D of Bausch Health Companies Inc and owns about 0 shares of Bausch Health Companies Inc (BHC) stock worth over $0. Details can be seen in Susan Hall's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Susan Hall has not made any transactions after 2015-11-11 and currently still holds the listed stock(s).

Transaction Summary of Susan Hall

To

Susan Hall Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susan Hall owns 2 companies in total, including Bausch Health Companies Inc () , and Endo International PLC () .

Click here to see the complete history of Susan Hall’s form 4 insider trades.

Insider Ownership Summary of Susan Hall

Ticker Comapny Transaction Date Type of Owner
Bausch Health Companies Inc 2012-03-07 SVP & Global Head of R&D
Endo International PLC 2015-11-11 EVP & CSO & Global Head of R&D

Susan Hall Latest Holdings Summary

Susan Hall currently owns a total of 2 stocks. Among these stocks, Susan Hall owns 7,515 shares of Endo International PLC (ENDPQ) as of November 11, 2015, with a value of $5 and a weighting of 100%. Susan Hall also owns 0 shares of Bausch Health Companies Inc (BHC) as of March 7, 2012, with a value of $0 and a weighting of 0%.

Latest Holdings of Susan Hall

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENDPQ Endo International PLC 2015-11-11 7,515 0.00 5
BHC Bausch Health Companies Inc 2012-03-07 0 8.53 0

Holding Weightings of Susan Hall


Susan Hall Form 4 Trading Tracker

According to the SEC Form 4 filings, Susan Hall has made a total of 0 transactions in Endo International PLC (ENDPQ) over the past 5 years. The most-recent trade in Endo International PLC is the acquisition of 1,000 shares on November 11, 2015, which cost Susan Hall around $55,350.

According to the SEC Form 4 filings, Susan Hall has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the sale of 16,120 shares on March 7, 2012, which brought Susan Hall around $878,540.

Insider Trading History of Susan Hall

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Susan Hall Trading Performance

GuruFocus tracks the stock performance after each of Susan Hall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan Hall is -14.19%. GuruFocus also compares Susan Hall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan Hall within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Susan Hall's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Susan Hall

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.08 -14.19 -76.02 -68.79 -64.98 -37.99
Relative Return to S&P 500(%) 4.1 -2.34 -75.51 -73.09 -76.54 -48.25

Susan Hall Ownership Network

Ownership Network List of Susan Hall

No Data

Ownership Network Relation of Susan Hall


Susan Hall Owned Company Details

What does Bausch Health Companies Inc do?

Who are the key executives at Bausch Health Companies Inc?

Susan Hall is the SVP & Global Head of R&D of Bausch Health Companies Inc. Other key executives at Bausch Health Companies Inc include EVP & General Counsel Seana Carson , SVP & Controller & CAO John S Barresi , and EVP & Chief Financial Officer Tom George Vadaketh .

Bausch Health Companies Inc () Insider Trades Summary

Over the past 18 months, Susan Hall made no insider transaction in Bausch Health Companies Inc (). Other recent insider transactions involving Bausch Health Companies Inc () include a net sale of 8,515 shares made by Seana Carson ,

In summary, during the past 3 months, insiders sold 0 shares of Bausch Health Companies Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,515 shares of Bausch Health Companies Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,515 shares.

Bausch Health Companies Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bausch Health Companies Inc Insider Transactions

No Available Data

Susan Hall Mailing Address

Above is the net worth, insider trading, and ownership report for Susan Hall. You might contact Susan Hall via mailing address: Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4 L2 00000.

Discussions on Susan Hall

No discussions yet.